Paterna BioSciences HoldCo discloses Form D equity offering of $11.2 million
The Salt Lake City biotechnology company reported $6.3 million sold to 17 investors as of a July 30, 2026 first sale date, according to an SEC filing signed August 12, 2026.
SEC filing